Abstract
l-Tyrosine polyphosphate (LTP), a “pseudo” poly (amino acid) polymer is characterized by a rapid degradation rate. Subsequently, formulation of a drug delivery system has been investigated by encapsulating fluorescein isothiocyanate–bovine serum albumin (FITC-BSA) within LTP microparticles. Characterization of surface morphology shows a mixture of spherical and discoid particles with a slightly rough surface morphology for all microparticle formulations. Dynamic laser light scattering (DLS) shows a decrease in particle diameters and size distribution upon FITC-BSA encapsulation. LTP microparticles are found to degrade over a period of 7 days, and complete release of FITC-BSA is observed over a period of 6 days. Cytotoxicity evaluation of LTP microparticles indicates that these microparticles do not cause severe cell death in cultured primary human dermal fibroblasts over a period of 10 days. Therefore, the LTP microparticles are promising candidates for short-term protein delivery applications.
Similar content being viewed by others
References
Banga AK, Chien YW (1988) Int J Pharm 48:15
Lee VHL (1987) Pharm Technol 11:26
Shire SJ (1987) Pharm Technol 11:34
Lee VH (1988) Crit Rev Ther Drug Carrier Syst 5:34
Langer R (2000) Acc Chem Res 33:94
Gombotz R, Pettit DK (1995) Bioconjug Chem 6:332
O'Hagan DT, Jeffrey H, Davis SS (1994) Int J Pharm 103:37
Ogawa Y, Yamamoto M, Okada T, Yashiki T, Shimamoto T (1998) Chem Pharm Bull 36:1095
Rafati H, Coomber AGA, Adler J, Holland J, Davis SS (1997) J Control Release 43:89
Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ (1997) J Control Release 43:197
Sen Gupta A, Lopina ST (2004) Polymer 45:4563
Sen Gupta A, Lopina ST (2005) Polymer 46:2133
Ditto AJ, Shah PN, Lopina ST, Yun YH (2009) Int J Pharm 368:199
Berkland C, Kipper MJ, Narasimhan B, Kyekyoon K, Pack DW (2004) J Control Release 94:129
Wei G, Pettway GJ, McCauley LK, Ma PX (2004) Biomaterials 25:345
Aubert-Pouessel A, Venier-Julienne MC, Clavreul A, Sergent M, Jollivet C, Montero-Menei CN, Garcion E, Bibby DC, Menei P, Benoit JP (2004) J Control Release 95:463
Yun YH, Goetz DJ, Yellen P, Chen W (2004) Biomaterials 25:147
Zisch AH, Luttolf MP, Hubbell JA (2003) Cardiovasc Pathol 12:295
Babensee JE, McIntire LV, Mikos AG (2000) Pharm Res 17(5):497
Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Nat Biotechnol 19:1029
Sun SW, Jeong YI, Jun SW, Kim SH (2003) J Microencapsul 20:479
Gorner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E (1999) J Control Release 57:259
McGee JP, Davis SS, O'Hagan DT (1995) J Control Release 34:77
Hariharan M, Price JC (2002) J Microencapsul 19:95
Zilberman M, Shraga I (2006) J Biomed Mater Res 79A:370
Wu XS (1995) Preparation, characterization, and drug delivery applications of microspheres based on biodegradable lactic/glycolic acid polymers. In: Wise DL (ed) Encyclopedic handbook of biomaterials and bioengineering. Marcel Dekker, New York, p 1151
Vishwanathan NB, Patil SS, Pandit JK, Lele AK, Kulkarni MG, Mashelkar RA (2001) J Microencapsul 18:783
International Organization of Standardization (1992) Biological evaluation of medical devices—part 5: tests for cytotoxicity: in vitro methods, ISO/DIS 10993–5 (EN 30993–5). International Organization of Standardization, Geneva
Ratner BD (2004) Introduction to testing biomaterials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (eds) Biomaterials science: an introduction to materials in medicine. Elsevier, New York, p 355
Kichler A, Leborgne C, Coyetaux E, Danos O (2001) J Gene Med 3:135
Amiji MM (1997) Carbohydr Polym 32:193
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shah, P.N., Puntel, A.A., Lopina, S.T. et al. Development and in vitro cytotoxicity of microparticle drug delivery system for proteins using l-tyrosine polyphosphate. Colloid Polym Sci 287, 1195–1205 (2009). https://doi.org/10.1007/s00396-009-2082-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00396-009-2082-4